TRANSPOSAGEN BIOPHARMACEUTICALS
Transposagen Biopharmaceuticals is a privately held biotechnology company that is dedicated to providing unique animal models of human diseases for drug discovery and development. Transposagen is currently focusing on the $1.2 billion/year rodent model market. The rodent model market is experiencing double-digit annual growth due to the research and development needs of the pharmaceutical industry. It was founded in 2003 and is headquartered in Lexington, Kentucky.
TRANSPOSAGEN BIOPHARMACEUTICALS
Industry:
Biotechnology Health Care Medical
Founded:
2003-10-23
Address:
Lexington, Kentucky, United States
Country:
United States
Website Url:
http://www.transposagenbio.com
Total Employee:
11+
Status:
Active
Contact:
8666075608
Email Addresses:
[email protected]
Total Funding:
6.67 M USD
Technology used in webpage:
Google Identity Platform Namecheap DNS Hawk Host
Similar Organizations
Asinex Corporation
Asinex Corporation provides screening libraries of lead-like molecules, macrocycles and fragments.
BioIntervene
BioIntervene is engages in drug discovery and development.
BioSeek
BioSeek provides cell-based human disease models for drug discovery and development.
Edison Pharmaceuticals
Edison Pharmaceuticals develops medicines for the treatments of children and adults diagnosed with rare and neglected diseases.
Gloucester Pharmaceuticals
Gloucester Pharmaceuticals acquires clinical-stage oncology drug candidates and advances them through approvals and commercialization.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
Qubit Pharmaceuticals
Qubit Pharmaceuticals is an EIT Health Headstart laureate and is incubated at Paris Biotech Santé.
Revero
Our mission is to reverse autoimmune and other chronic diseases by addressing the root causes
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Xceleron Inc.
Xceleron provides Accelerator Mass Spectrometry to deliver ultra-sensitive analytical solutions for drug development.
Founder
Official Site Inspections
http://www.transposagenbio.com
- Host name: 177.185.96.172.static.reverse.arandomserver.com
- IP address: 172.96.185.177
- Location: Fergus Canada
- Latitude: 43.7001
- Longitude: -80.3664
- Timezone: America/Toronto
- Postal: N1M
More informations about "Transposagen Biopharmaceuticals"
Transposagen Biopharmaceuticals - Crunchbase Company Profile …
Contact Email [email protected] Phone Number 8666075608 Transposagen Biopharmaceuticals is a privately held biotechnology company that is dedicated to providing …See details»
Transposagen Company Profile 2024: Valuation, …
Transposagen General Information Description. Developer of biotechnology drugs intended to improve drug discovery and development research. The company is biotechnology-based and provides genetically modified rat models to create …See details»
Transposagen Biopharmaceuticals, Inc., - Lexington, USA
Transposagenbio.com. Contact. Profile News. Contact. About Transposagen. Company Overview Transposagen, Inc. is a privately-held biotechnology company founded in 2005 to …See details»
Transposagen Biopharmaceuticals, Inc. (Transposagen …
Www.transposagenbio.com. ... He joined Celgene in 2015, serving as president of the research and early development organization. Prior to that, he held roles at Merck & Co. and GSK. …See details»
Transposagen Biopharmaceuticals Inc - Company Profile and News
Company profile page for Transposagen Biopharmaceuticals Inc including stock price, company news, executives, board members, and contact informationSee details»
Transposagen Biopharmaceuticals, Inc | Lexington, KY, USA Startup …
Website transposagenbio.com; Company Summary Transposagen Biopharmaceuticals, Inc. (Transposagen), is a privately held biotechnology company that is dedicated to providing …See details»
TRANSPOSAGEN BIOPHARMACEUTICALS, INC. - VentureRadar
Similar Companies: GENOWAY France Publicly Traded Develoment and marketing of genetically modified animal models for the biopharmaceuticals, chemical, agrochemicals and food …See details»
Transposagen Biopharmaceuticals - Company Profile & Staff …
Company Overview Transposagen, Inc. is a privately-held biotechnology company founded in 2005 to commercialize early gene editing technology for the construction of rodent models of …See details»
Transposagen Biopharmaceuticals Company Profile | Management …
[email protected]: Transposagen Biopharmaceuticals Top Competitors. Company Employees Revenue Top technologies; System Biosciences Inc. 23: $13.7 M: TransViragen …See details»
Transposagen Biopharmaceuticals - Golden
Transposagen was founded in 2003 to commercialize early gene editing technology. Since then, Transposagen has merged with Hera BioLabs and has increased its scientific offerings to …See details»
Transposagen Biopharmaceuticals - Overview, News & Similar
Who is Transposagen Biopharmaceuticals. Transposagen Biopharmaceuticals, Inc., a biotechnology company, provides animal models, cell lines, stem cells, and research tools and …See details»
Transposagen Biopharmaceuticals - Products, Competitors, …
Headquarters Location. 2277 Thunderstick Drive, #500 . Lexington, Kentucky, 40508, United States. 859-428-8561See details»
Transposagen Biopharmaceuticals, Inc. Expands Field of Use
Oct 15, 2009 The company’s signature product, TKO((TM)) Knockout Rat Models, mimic human diseases and are used for drug discovery and development research. The production of …See details»
Aragen Bioscience, Inc. and Transposagen - GlobeNewswire
Jun 16, 2015 Aragen Bioscience, Inc. is a privately held contract research organization with offices and laboratories in the San Francisco Bay Area. ... Sales & Marketing Transposagen …See details»
TRANSPOSAGEN BIOPHARMACEUTICALS, INC. | VentureRadar
Website: http://www.transposagenbio.com/ Transposagen Biopharmaceuticals provides unique animal models and other research tool technologies to improve drug discovery ...See details»
Transposagen Biopharmaceuticals - CB Insights
Funding, Valuation & Revenue. 6 Fundings. Transposagen Biopharmaceuticals has raised $7.01M over 6 rounds.. Transposagen Biopharmaceuticals's latest funding round was a Grant …See details»
Stemgent, a ReproCELL Group Company and Transposagen
Feb 18, 2015 CAMBRIDGE, Mass. and LEXINGTON, Ky., Feb. 18, 2015 (GLOBE NEWSWIRE) -- Stemgent, Inc., A ReproCELL Group Company (Cambridge, Massachusetts, USA) and …See details»
Transposagen Biopharmaceuticals, Inc. Expands Field of Use
Oct 15, 2009 For more information, visit www.transposagenbio.com. About Notre Dame: The University of Notre Dame, founded in 1842 by Rev. Edward F. Sorin, C.S.C., of the …See details»
Transposagen Biopharmaceuticals, Inc. Wins Prestigious
LEXINGTON, Ky., June 16, 2015 (GLOBE NEWSWIRE) -- Transposagen Biopharmaceuticals, Inc. (“Transposagen”), a privately-held biotechnology company, has accepted the highly …See details»
Transposagen Biopharmaceuticals, Inc. announces the availability …
Jul 17, 2012 /PRNewswire/ -- Transposagen announced that XTN™ site-specific nucleases targeting each gene in the human genome are now available. Utilizing the FLASH™...See details»